Soleno Therapeutics, Inc. (SLNO) Tops Q3 EPS by 42c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q3 EPS of $0.47, $0.42 better than the analyst estimate of $0.05. Revenue for the quarter came in at $66 million versus the consensus estimate of $47.46 million.

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• Putin Said To Plan Ukraine Escalation, Seeing Talks Fruitless - Bloomberg
• Burlington Stores (BURL) September 4 weekly 310, September 335, September 25 weekly 305, October 340 puts active into quarter results
• IREN Limited (IREN) call put ratio 3.4 calls to 1 put into quarter results